take a look at PXS announcement 23/11/09 (I think) - was having a look last night - the FDA advisory committee (different one obviously) met on Aridol giving it thumbs up, but noting the votes for, against and abstain, for the various age groups.
Interestingly the committee gave a reasonably resounding yes but FDA knocked back in December, albeit on a few minor issues (I hope) and PXS are expecting approval to come through this quarter.
Assume this can be a guide as to what to expect this Thurs. Not long now - what suspense the last few weeks have been.
Regards Scott
CXS Price at posting:
85.5¢ Sentiment: Buy Disclosure: Held